[1]
Glynne-Jones, R. et al. 2020. A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES). Archives of Clinical and Biomedical Research. 4, 4 (Aug. 2020), 394–412.